Can persistent post-infectious immune signaling worsen cognition in vulnerable older adults?

Persistent post-infectious immune activation is a credible contributor to systemic inflammation and may interact with brain glial responses relevant to cognitive vulnerability in later life. The overall evidence supports association and biologic plausibility, rather than establishing a single causal pathway in an individual 77-year-old man.

Clinical and longitudinal evidence

• Post-COVID prospective cohorts found that people developing post-acute sequelae had higher early TNF-α and IP-10 and later IL-6; a small longitudinal study also identified proinflammatory cytokine and immune-cell changes persisting 7–11 months after infection.
• In cognitively vulnerable populations, inflammatory/glial biomarkers track poorer cognitive trajectories. In Swedish BioFINDER, higher CSF YKL-40 was associated with lower baseline MMSE and faster longitudinal decline.
• Plasma and CSF GFAP, CSF CCL2, and combined plasma GFAP/p-tau181 measures have also predicted later cognitive decline. Notably, plasma and CSF GFAP associations persisted after accounting for amyloid-PET change, supporting relevance beyond amyloid accumulation alone.

Mechanistic interpretation

• Peripheral inflammatory challenges can activate microglia and brain inflammatory mediators in preclinical models. In humans with persistent post-infectious symptoms, a symptomatic subset assessed about two years after infection had increased cerebral TSPO-PET binding, compatible with altered glial/inflammatory signaling.
• GFAP reflects astrocytic reactivity, while YKL-40 and TSPO-PET reflect broad, non-cell-specific inflammatory/glial processes. These markers cannot establish whether inflammation is harmful, protective, or secondary to neurodegeneration.

Clinical implications

• Neuroinflammatory activity may contribute to, or mark, accelerated decline in people with MCI or Alzheimer-spectrum pathology, but vascular disease, frailty, medications, infection, and underlying neurodegeneration can modify these relationships.
• TSPO-PET and inflammatory biomarkers remain research tools, not stand-alone diagnostic or prognostic tests.

Bottom line

• Persistent post-infectious signaling is associated with systemic cytokine activity; downstream neuroinflammation and cognitive worsening in vulnerable older adults are biologically plausible and moderately supported, but not proven as an individual-level causal explanation.